{"mainPropery":{"diseaseId":12967,"diseaseName":"Reticulohistiocytoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12967/reticulohistiocytoma","synonyms":["Solitary reticulohistiocytosis","Solitary histiocytoma"],"synonyms-with-source":[{"name":"Solitary reticulohistiocytosis","source":"DemaNetNZ"},{"name":"Solitary histiocytoma","source":"DemaNetNZ"}],"identifiers":[]},"diseaseCategories":[],"organizations":[{"resourceID":73,"resourceName":"Histiocytosis Association","abbreviation":"","address1":"332 North Broadway","address2":"","address3":"","address4":"","address5":"","city":"Pitman","state":"NJ","zip":"08071 ","country":"United States","phone":"+1-856-589-6606","tty":"","tollFree":"1-800-548-2758 (from US and Canada)","fax":"+1-856-589-6614","email":"info@histio.org","url":"https://www.histio.org/","freeText":""},{"resourceID":74,"resourceName":"Histiocytosis Association of Canada","abbreviation":"","address1":"41 Milverton Close","address2":"Waterdown, ON  ","address3":"L8B 0A9 ","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"","tty":"","tollFree":"","fax":"","email":"info@histio.ca","url":"https://histiocytosis.ca/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=reticulohistiocytoma' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Reticulohistiocytoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/dermal-infiltrative/reticulohistiocytosis.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":193,"questionText":"What is reticulohistiocytoma?","answerText":"<strong>Reticulohistiocytoma (RH)&nbsp;</strong>is a rare benign lesion of the soft tissue. It belongs to a group of disorders called <a href=\"http://www.dermnetnz.org/dermal-infiltrative/non-langerhans.html\" target=\"_blank\">non-Langerhans cell histiocytosis</a> and&nbsp;is a type of <a href=\"http://www.dermnetnz.org/dermal-infiltrative/reticulohistiocytosis.html\" target=\"_blank\">reticulohistiocytosis</a>, all of which are types of&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000068.htm\" target=\"_blank\">histiocytosis</a>.[11019][11021] Histiocytosis is&nbsp;a&nbsp;condition in which there is rapid production (proliferation) of histiocytes (immune cells) in the skin or soft tissues.[138] The stimulus that causes the immune system to react in RH is currently not well understood.[11019] RH present as a yellow to reddish-brown smooth surfaced, firm nodule or lesion  on the trunk and/or extremities of the body.[11021] Historically, RH has been found in young adults, with a slightly higher incidence in males.[11019] RH typically resolve spontaneously over a period of months to years, are not associated with systemic disease, and do not otherwise affect health. Treatment  involves surgical removal of the lesion.[139]","dateModified":"2016-03-31T00:00:00"},"basicQuestions":[{"questionId":197,"questionText":"What causes reticulohistiocytoma?","answerText":"While it is known that reticulohistiocytoma (RH) develop due to a rapid production of immune cells (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002374.htm\" target=\"_blank\">histiocytes</a>) in the skin or soft tissues, the cause of this process is not currently known.[137][11019]","dateModified":"2016-03-31T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":137,"authors":"Miettinen M, Fetsch JF","articleTitle":"Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases","bookWebsiteJournalTitle":"Am J Surg Pathol.","date":"2006","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/16625100","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11019,"authors":"Heather M. Weissman, Brent R. Hayek, Hans E. Grossniklaus","articleTitle":"Reticulohistiocytoma of the Orbit","bookWebsiteJournalTitle":"Ophthal Plast Reconstr Surg","date":"August 25, 2015","volume":"31(1)","pages":"e13-e16","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548269/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":195,"questionText":"How is reticulohistiocytoma diagnosed?","answerText":"The diagnosis of reticulohistiocytoma (RH) is made based on clinical presentation, histology, and immunohistochemistry profile. RH occur in isolation and are typically described as small, yellow to reddish-born nodules. The lesions usually are slightly elevated from the surrounding skin.[137][139][11021] Detailed information on <a href=\"http://www.dermnetnz.org/pathology/reticulohistiocytoma-path.html\" target=\"_blank\">histology of reticulohistiocytoma</a> is available through DermNet NZ, an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated.<br />\r\n<br />\r\nThere are several differential diagnoses for RH. It is important to distinguish RH from <a href=\"https://www.histio.org/page.aspx?pid=399#.Vv7F_fkrJhE\" target=\"_blank\">Rosai-Dorfman disease</a>, <a href=\"http://www.dermnetnz.org/lesions/xanthogranuloma.html\" target=\"_blank\">juvenile xanthogranuloma</a>, a variety of <a href=\"http://www.mayoclinic.org/granuloma/expert-answers/faq-20057838\" target=\"_blank\">granulomatous</a> conditions, and some malignant neoplasms, including <a href=\"http://www.histiocytosis.ucdavis.edu/sarcoma.html\" target=\"_blank\">histiocytic sarcoma</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/melanoma.html\" target=\"_blank\">melanoma</a>, and <a href=\"http://sarcomahelp.org/epithelioid-sarcoma.html\" target=\"_blank\">epithelioid sarcoma</a>.[137] <br />\r\n<br />\r\nReticulohistiocytoma should also be distinguished from <a href=\"https://rarediseases.info.nih.gov/gard/7103/multicentric-reticulohistiocytosis/resources/1\" target=\"_blank\">multicentric reticulohistiocytosis</a>. [139]","dateModified":"2016-04-01T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":137,"authors":"Miettinen M, Fetsch JF","articleTitle":"Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases","bookWebsiteJournalTitle":"Am J Surg Pathol.","date":"2006","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/16625100","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":139,"authors":"","articleTitle":"Reticulohistiocytosis","bookWebsiteJournalTitle":"DermNet NZ","date":"Dec 28, 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/dermal-infiltrative/reticulohistiocytosis.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11021,"authors":"A. Tulin Gulec","articleTitle":"Solitary reticulohistiocytoma with arborizing vessels: A new mimicker of basal cell carcinoma","bookWebsiteJournalTitle":"Journal of the American Academy of Dermatology","date":"January 2016","volume":"74(1)","pages":"e5-e6","url":"http://www.ncbi.nlm.nih.gov/pubmed/26702812","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":198,"questionText":"How might reticulohistiocytoma be treated?","answerText":"Reticulohistiocytoma (RH) typically resolve spontaneously over a period of months to years; however, surgical excision usually results in a cure.[139] <br />\r\n<br />","dateModified":"2016-03-31T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":139,"authors":"","articleTitle":"Reticulohistiocytosis","bookWebsiteJournalTitle":"DermNet NZ","date":"Dec 28, 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/dermal-infiltrative/reticulohistiocytosis.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":194,"questionText":"What is the long-term outlook for reticulohistiocytoma?&nbsp;","answerText":"The long-term outlook (prognosis) for Reticulohistiocytoma (RH) is good. RH is thought to represent a benign skin lesion. RH tends to spontaneously resolve over a period of months to years and affected individuals remain healthy.[139] Recurrence of RH is rare.[11103]<br />","dateModified":"2016-03-31T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":139,"authors":"","articleTitle":"Reticulohistiocytosis","bookWebsiteJournalTitle":"DermNet NZ","date":"Dec 28, 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/dermal-infiltrative/reticulohistiocytosis.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11103,"authors":"Philip R. Cohen, Robert A Lee","articleTitle":"Adult-onset reticulohistiocytoma presenting as a solitary asymptomatic red knee nodule: report and review of clinical presentations and immunohistochemistry staining features of reticulohistiocytosis.","bookWebsiteJournalTitle":"Dermatol Online J","date":"March 17, 2014","volume":"20(3)","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/24656263","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":11020,"authors":"","articleTitle":"Reticulohistiocytoma pathology","bookWebsiteJournalTitle":"DermNetNZ","date":"February, 2015","volume":"","pages":"","url":"http://www.dermnetnz.org/pathology/reticulohistiocytoma-path.html","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Reticulohistiocytoma"}